Equities

Bio-Thera Solutions Ltd

688177:SHH

Bio-Thera Solutions Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)23.75
  • Today's Change-0.45 / -1.86%
  • Shares traded2.79m
  • 1 Year change-35.27%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4497751,436
Total Receivables, Net211114155
Total Inventory23116290
Prepaid expenses739175
Other current assets, total462114
Total current assets1,0101,1621,770
Property, plant & equipment, net1,014783587
Goodwill, net------
Intangibles, net230234239
Long term investments10.00----
Note receivable - long term------
Other long term assets------
Total assets2,2872,1802,618
LIABILITIES
Accounts payable1718446
Accrued expenses545248
Notes payable/short-term debt1063.3633
Current portion long-term debt/capital leases533.492.38
Other current liabilities, total340396397
Total current liabilities725539526
Total long term debt3246.010
Total debt4841336
Deferred income tax------
Minority interest------
Other liabilities, total25284.23
Total liabilities1,074572530
SHAREHOLDERS EQUITY
Common stock414414414
Additional paid-in capital3,0543,0543,054
Retained earnings (accumulated deficit)(2256)(1861)(1381)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.000.01(0.13)
Total equity1,2131,6072,088
Total liabilities & shareholders' equity2,2872,1802,618
Total common shares outstanding414414414
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.